These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17628298)

  • 1. Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder.
    Das K; Zhao Y; Sugiono M; Lau W; Tan PH; Cheng C
    Urol Oncol; 2007; 25(4):317-21. PubMed ID: 17628298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of endothelial delta-like 4 expression correlates with vessel maturation in bladder cancer.
    Patel NS; Dobbie MS; Rochester M; Steers G; Poulsom R; Le Monnier K; Cranston DW; Li JL; Harris AL
    Clin Cancer Res; 2006 Aug; 12(16):4836-44. PubMed ID: 16914569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder.
    Liu L; Zhu D; Gao R; Guo H
    Urol Int; 2008; 81(1):72-6. PubMed ID: 18645275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker.
    Pignot G; Bieche I; Vacher S; Güet C; Vieillefond A; Debré B; Lidereau R; Amsellem-Ouazana D
    Eur Urol; 2009 Oct; 56(4):678-88. PubMed ID: 18513850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer.
    Crew JP; O'Brien T; Bradburn M; Fuggle S; Bicknell R; Cranston D; Harris AL
    Cancer Res; 1997 Dec; 57(23):5281-5. PubMed ID: 9393750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial comment on: Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker.
    Shariat SF
    Eur Urol; 2009 Oct; 56(4):688-9. PubMed ID: 18513852
    [No Abstract]   [Full Text] [Related]  

  • 8. VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
    Bates DO; Cui TG; Doughty JM; Winkler M; Sugiono M; Shields JD; Peat D; Gillatt D; Harper SJ
    Cancer Res; 2002 Jul; 62(14):4123-31. PubMed ID: 12124351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of vascular endothelial growth factor a dynamic expression in transitional cell carcinoma.
    Ping SY; Shen KH; Yu DS
    Mol Carcinog; 2013 Jul; 52(7):568-79. PubMed ID: 22392726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of vascular endothelial growth factor in transitional cell carcinoma of urinary bladder is correlated with cancer progression.
    Yang CC; Chu KC; Yeh WM
    Urol Oncol; 2004; 22(1):1-6. PubMed ID: 14969795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual role of carcinoembryonic antigen-related cell adhesion molecule 1 in angiogenesis and invasion of human urinary bladder cancer.
    Oliveira-Ferrer L; Tilki D; Ziegeler G; Hauschild J; Loges S; Irmak S; Kilic E; Huland H; Friedrich M; Ergün S
    Cancer Res; 2004 Dec; 64(24):8932-8. PubMed ID: 15604255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative and quantitative analysis of angiogenetic factors in transitional cell bladder carcinoma: relationship with clinical course at 10 years follow-up.
    Bartoletti R; Cai T; Nesi G; Sardi I; Rizzo M
    Oncol Rep; 2005 Jul; 14(1):251-5. PubMed ID: 15944797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor.
    Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I
    Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenic profile of uveal melanoma.
    Notting IC; Missotten GS; Sijmons B; Boonman ZF; Keunen JE; van der Pluijm G
    Curr Eye Res; 2006 Sep; 31(9):775-85. PubMed ID: 16966150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma].
    Guo ZH; Mei H; Huang J; Li SY
    Ai Zheng; 2003 Mar; 22(3):307-9. PubMed ID: 12654193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
    Junttila TT; Laato M; Vahlberg T; Söderström KO; Visakorpi T; Isola J; Elenius K
    Clin Cancer Res; 2003 Nov; 9(14):5346-57. PubMed ID: 14614020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder.
    Chikazawa M; Inoue K; Fukata S; Karashima T; Shuin T
    Pathobiology; 2008; 75(6):335-45. PubMed ID: 19096229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase expression in the recurrence of superficial low grade bladder transitional cell carcinoma.
    Choi YD; Cho NH; Ahn HS; Cho KS; Cho SY; Yang WJ
    J Urol; 2007 Mar; 177(3):1174-8. PubMed ID: 17296440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemo-angiogenic profile of bovine urinary bladder tumors distinguishes urothelial carcinomas from hemangiosarcomas.
    Carvalho T; Elias AP; Nunes T; Peleteiro MC; Dias S
    Vet Immunol Immunopathol; 2008 Feb; 121(3-4):344-58. PubMed ID: 18022698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A.
    Talbot SG; O-charoenrat P; Sarkaria IS; Ghossein R; Reddy P; Ngai I; Cordeiro CN; Wong RJ; Kris MG; Rusch VW; Singh B
    Ann Surg Oncol; 2004 May; 11(5):530-4. PubMed ID: 15123463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.